中文名 | 盐酸瑞伐拉赞 |
---|---|
英文名 | Revaprazan Hydrochloride |
英文别名 |
T66 CNT&J B1 C- DT6N CNJ BMR DF& E1 F1 &&HCl
N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-2(1H)-isoquinolinyl)-2-pyrimidinamine hydrochloride (1:1) 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine, monohydrochloride N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-amine hydrochloride Revanex 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, monohydrochloride Revaprazan HCL 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, hydrochloride (1:1) YH1885 |
描述 | Revaprazan hydrochloride 是一种新型酸泵拮抗剂 (APA)。 Revaprazan hydrochloride 可降低 COX-2 的表达,并在幽门螺杆菌感染中具有显着的抗炎作用。 |
---|---|
相关类别 | |
靶点 |
Acid pump; COX-2[1] |
参考文献 |
熔点 | 205-208° |
---|---|
分子式 | C22H24ClFN4 |
分子量 | 398.904 |
精确质量 | 398.167358 |
PSA | 41.05000 |
LogP | 6.03980 |
储存条件 | 2-8°C |